NEW YORK (GenomeWeb) – D-Mark Biosciences will distribute Sygnis' TruePrime Single Cell WGA kit in Canada as part of a non-exclusive deal that Sygnis announced today.
D-Mark will promote, market, and sell the kit, which eliminates the need for synthetic random primers in whole-genome amplification. The kit is based on the recently discovered DNA primase TthPrimPol and the Phi29 polymerase and is the first of a number of anticipated products under the TruePrime name, Sygnis said.
TruePrime Single Cell WGA is already available in Europe, and Sygnis CEO and CFO Pilar de la Huerta said in a statement that launching the product in North America is the "next logical step and a further milestone in our product and commercialization strategy."
Financial and other terms of the deal were not disclosed.
Sygnis develops products for molecular biology with a focus on polymerases with applications in DNA amplification and sequencing, and has offices and laboratories in Madrid and Heidelberg, Germany. D-Mark is headquartered in Toronto and provides research reagents and instruments to molecular biologists.